Related Experiment Video

Updated: Jul 9, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)

Published on: February 9, 2011

Severe pneumonia combined with septic shock caused by community-acquired methicillin-resistant Staphylococcus aureus

Linya He1, Jian Wang2, Yaxin Ning3

  • 1The Second Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.

Medicine
|March 28, 2025
PubMed
Abstract

Insights

Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) pneumonia is a severe infection. Venovenous extracorporeal membrane oxygenation (ECMO) can be life-saving for patients with respiratory failure from CA-MRSA pneumonia when conventional ventilation fails.

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Pulmonology

Background:

  • Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) pneumonia is a severe, rapidly progressing infection.
  • It can lead to acute respiratory distress syndrome (ARDS) and septic shock.
  • Venovenous extracorporeal membrane oxygenation (ECMO) may improve outcomes in critically ill patients failing conventional mechanical ventilation.

Purpose of the Study:

  • To report on the successful use of venovenous ECMO in two patients with severe CA-MRSA pneumonia.
  • To highlight the critical role of ECMO in managing life-threatening respiratory failure and septic shock caused by CA-MRSA.

Main Methods:

  • Two female patients (14 and 32 years) presented with severe pneumonia and hemodynamic instability.
  • Diagnosis of CA-MRSA pneumonia complicated by ARDS and septic shock was confirmed.
  • Treatment included targeted antibiotics (linezolid), venovenous ECMO for respiratory support, and hemodynamic management.

Main Results:

  • Both patients showed significant clinical improvement after ECMO initiation and targeted therapy.
  • Lung function recovered, and they were successfully weaned from ECMO and mechanical ventilation.
  • Both patients were discharged with favorable outcomes.

Conclusions:

  • CA-MRSA pneumonia requires aggressive intervention due to rapid progression to respiratory failure and septic shock.
  • Venovenous ECMO, coupled with appropriate antibiotics, can be life-saving.
  • Early recognition, multidisciplinary care, and ECMO are crucial for severe CA-MRSA pneumonia management.

More Related Videos

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse06:41

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse

Published on: October 24, 2018

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...